0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Familial Primary Pulmonary Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Familial Primary Pulmonary Hypertension - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Microvascular Angina - Pipeline Insight, 2025 - Product Thumbnail Image

Microvascular Angina - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Hypercholesterolemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypercholesterolemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Arteriovenous Malformations - Pipeline Insight, 2025 - Product Thumbnail Image

Arteriovenous Malformations - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Gene Therapies For Cardiomyopathies - Pipeline Insight, 2025 - Product Thumbnail Image

Gene Therapies For Cardiomyopathies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Retinal Edema - Pipeline Insight, 2025 - Product Thumbnail Image

Retinal Edema - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Ventricular Hypertrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Ventricular Hypertrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Hyperlipidemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperlipidemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Ventricular Tachycardia (V-tach Or VT) - Pipeline Insight, 2025 - Product Thumbnail Image

Ventricular Tachycardia (V-tach Or VT) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Abdominal Aortic Aneurysm - Pipeline Insight, 2025 - Product Thumbnail Image

Abdominal Aortic Aneurysm - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Advanced Heart Failure - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Heart Failure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Acute Heart Failure - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Heart Failure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
EUR$1,500USDGBP
Intracranial Arterial Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Intracranial Arterial Diseases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Anti-hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-hypertension - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Dyslipidemia - Pipeline Insight, 2025 - Product Thumbnail Image

Dyslipidemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Early Cardiogenic Shock (CS) - Pipeline Insight, 2025 - Product Thumbnail Image

Early Cardiogenic Shock (CS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
No Option Refractory Disabling Angina (NORDA) - Pipeline Insight, 2025 - Product Thumbnail Image

No Option Refractory Disabling Angina (NORDA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
From
EUR$2,000USDGBP
Post-Cardiac Arrest Syndrome (PCAS) - Pipeline Insight, 2025 - Product Thumbnail Image

Post-Cardiac Arrest Syndrome (PCAS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Pulmonary Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Pulmonary Hypertension - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
EUR$2,500USDGBP
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more